2595 — GenFleet Therapeutics (Shanghai) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$9.57bn
- HK$9.27bn
- CNY104.70m
Annual cashflow statement for GenFleet Therapeutics (Shanghai), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -508 | -678 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 277 | 406 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 11 | 51.3 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -202 | -206 |
| Capital Expenditures | -0.594 | -0.236 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 264 | 0.966 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Change in Net Investments | ||
| Purchase of Investments | ||
| Change in Net Intangibles | ||
| Cash from Investing Activities | 263 | 0.73 |
| Financing Cash Flow Items | -6.2 | -15.1 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -29.1 | 233 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 36.9 | 29.9 |